NASDAQ:CRVS | Key Financial Ratios | Corvus Pharmaceuticals, Inc.

Complete source-backed ratio history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-3016.16-22.62%-24.02%
2026-03-3119.81-17.44%-18.35%
2025-12-316.21-21.49%-24.97%
2025-09-308.29-18.73%-21.01%
2025-06-308.91-50.45%-56.26%
2025-03-314.9-69.65%-83.93%
2024-12-311.54-90.40%-191.27%
2024-09-300.92-96.63%-458.00%
2024-06-303.62-35.03%-44.15%
2024-03-313.4-62.01%-74.50%
2023-12-314.07-59.34%-69.87%
2023-09-304.53-58.13%-68.17%
2023-06-304.82-67.23%-78.86%
2023-03-314.29-70.25%-83.66%
2022-12-314.06-60.53%-73.61%
2022-09-303.67-50.69%-62.97%
2022-06-305.8-39.52%-45.49%
2022-03-316.95-39.45%-44.54%
2021-12-317.36-39.51%-44.50%
2021-09-306.97-5.58%-6.33%
2021-06-305.59-5.28%-6.00%
2021-03-314.94-4.25%-4.92%
2020-12-313.73-7.01%-8.31%
2020-09-304.38-79.46%-104.81%
2020-06-305.24-71.05%-89.69%
2020-03-315.96-64.99%-79.89%
2019-12-317.76-55.80%-65.63%
2019-09-309.23-49.89%-57.37%
2019-06-309.17-44.25%-50.89%
2019-03-3112.39-39.43%-43.97%
2018-12-3116.45-39.70%-42.54%
2018-09-3016.07-38.01%-40.69%
2018-06-3013.75-36.67%-39.70%
2018-03-3113.69-36.27%-39.30%
2017-12-3110.17-58.73%-65.61%
2017-09-3010.11-52.32%-58.48%
2017-06-3011.73-45.37%-50.01%
2017-03-3116.24-36.24%-38.96%
2016-12-3122.89-25.95%-27.39%
2016-09-3026.1-20.92%-21.92%
2016-06-3042.55-15.41%-15.91%
2016-03-3145.54-22.75%-23.45%
2015-12-3131.16-31.83%100.75%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-316.21-21.49%-24.97%
2024-12-311.54-90.40%-191.27%
2023-12-314.07-59.34%-69.87%
2022-12-314.06-60.53%-73.61%
2021-12-317.36-39.51%-44.50%
2020-12-313.73-7.01%-8.31%
2019-12-317.76-55.80%-65.63%
2018-12-3116.45-39.70%-42.54%
2017-12-3110.17-58.73%-65.61%
2016-12-3122.89-25.95%-27.39%
2015-12-3131.16-31.83%100.75%
2014-12-31101.26%